Harada S, Sugiyama E, Takebe S, Taki H, Shinoda K, Mohamed S G, Maruyama M, Hamazaki T, Kobayashi M
First Department of Internal Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan.
Clin Exp Rheumatol. 2003 Nov-Dec;21(6):753-8.
To clarify the role of interleukin-4 (IL-4) in the expression of 15-lipoxygenase (15-LOX), whose metabolities are known to suppress the inflammatory reaction, in freshly prepared rheumatoid synovial cells.
Adherent synovial cells were prepared by enzymatic digestion of synovia obtained from patients with rheumatoid arthritis (RA). Protein expression of 15-LOX was determined by Western blot analysis. The messenger RNAs of 15-LOX were determined by reverse transcription and the polymerase chain reaction (RT-PCR).
Freshly prepared rheumatoid synovial cells did not express 15-LOX at either the mRNA or protein levels. IL-4 induced the protein expression of 15-LOX after 24 hours of culture. Although interleukin-1 alpha (IL-1 alpha) and tumor necrosis factor alpha (TNF alpha), major inflammatory cytokines in rheumatoid synovia, did not induce the expression of 15-LOX, IL-4 and these inflammatory cytokines synergistically enhanced the protein expression of 15-LOX. The synergistic effect was also observed at the level of mRNA.
We demonstrate that IL-4 cooperated with the inflammatory cytokines IL-1 alpha and TNF alpha to enhance the expression of 15-LOX in rheumatoid synovial cells. Since 15-LOX metabolites have potent anti-inflammatory actions, our data suggest that IL-4 might downregulate rheumatoid inflammation via the induction of 15-LOX and its metabolites.
阐明白细胞介素-4(IL-4)在新鲜制备的类风湿性滑膜细胞中对15-脂氧合酶(15-LOX)表达的作用,已知该酶的代谢产物可抑制炎症反应。
通过酶消化从类风湿性关节炎(RA)患者获得的滑膜制备贴壁滑膜细胞。通过蛋白质印迹分析确定15-LOX的蛋白质表达。通过逆转录和聚合酶链反应(RT-PCR)确定15-LOX的信使核糖核酸。
新鲜制备的类风湿性滑膜细胞在mRNA或蛋白质水平均不表达15-LOX。培养24小时后,IL-4诱导了15-LOX的蛋白质表达。虽然类风湿性滑膜中的主要炎性细胞因子白细胞介素-1α(IL-1α)和肿瘤坏死因子α(TNFα)未诱导15-LOX的表达,但IL-4与这些炎性细胞因子协同增强了15-LOX的蛋白质表达。在mRNA水平也观察到了协同作用。
我们证明IL-4与炎性细胞因子IL-1α和TNFα协同作用,增强类风湿性滑膜细胞中15-LOX的表达。由于15-LOX代谢产物具有强大的抗炎作用,我们的数据表明IL-4可能通过诱导15-LOX及其代谢产物来下调类风湿性炎症。